title: The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
abstract: Cytotoxic T lymphocytes (CTLs) play a dominant role in the pathogenesis of autoimmune diabetes, commonly denoted Type 1 Diabetes (T1D). These CTLs (notably CD8(+) T cells) recognize and kill insulin-secreting pancreatic beta cells, reducing their number by approximately 90%. The resulting reduction of insulin secretion causes the defective regulation of glucose metabolism, leading to the characteristic symptoms of diabetes. Recognition of beta cells as targets by CTLs depends on the interactions between MHC-peptide complexes on the surface of beta cells and receptors (TCRs) on T cells. Those CTLs with high affinity TCRs (also called high avidity T cells) cause most of the harm, while those with low affinity TCRs (also called low avidity T cells) play a more mysterious role. Recent experimental evidence suggests that low avidity T cells accumulate as memory T cells during the disease and may be protective in NOD mice (a strain prone to developing T1D), delaying disease progression. It has been hypothesized that such low avidity T cells afford disease protection either by crowding the islets of Langerhans, where beta cells reside, or by killing antigen presenting cells (APCs). In this paper, we explore the hypothesized mechanisms for this protective effect in the context of a series of models for (1) the interactions of low and high avidity T cells, (2) the effect of APCs and (3) the feedback from beta cell killing to autoantigen-induced T cell proliferation. We analyze properties of these models, noting consistency of predictions with observed behaviour. We then use the models to examine the influence of various treatment strategies on the progression of the disease. The model reveals that progressive accumulation of memory low avidity autoreactive T cells during disease progression makes treatments aimed at expanding these protective T cell types more effective close to, or at the onset of clinical disease. It also provides evidence for the hypothesis that low avidity T cells kill APCs (rather than the alternate hypothesis that they crowd the islets).
authors.affiliation: Department of Mathematics, University of British Columbia, Vancouver, British Columbia, Canada. akhadra@iam.ubc.ca
authors.forename: Anmar
authors.initials: A
authors.lastname: Khadra
authors.forename: Pere
authors.initials: P
authors.lastname: Santamaria
authors.forename: Leah
authors.initials: L
authors.lastname: Edelstein-Keshet
mesh_terms: D000818:Animals; D000938:Antigen-Presenting Cells / Q000473:pathology; D015551:Autoimmunity; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology* / Q000473:pathology; D006801:Humans; D050417:Insulin-Secreting Cells / Q000276:immunology* / Q000473:pathology; D051379:Mice; D016688:Mice, Inbred NOD; D018448:Models, Immunological; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D017634:Self Tolerance; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D011948:Receptors, Antigen, T-Cell